Literature DB >> 29099566

Colorectal Cancer Screening.

Christopher Bray, Lauren N Bell, Hong Liang, Dennis Collins, Steven H Yale.   

Abstract

Colorectal cancer (CRC) continues to be one of the most commonly diagnosed cancers and contributes significantly to many cancer-related deaths despite sustained progress in diagnostic and treatment options. Many forms of CRC can be prevented through early and routine screening, when precancerous lesions may be detected and removed before they undergo malignant transformation or metastasis. Despite widespread efforts to improve CRC screening rates, at least 40% of age-eligible adults do not adhere to screening guidelines. A new generation of noninvasive, molecular-based diagnostic tests with high sensitivities and specificities has the potential to improve screening rates through optimal risk stratification of patients who may benefit from more invasive screening techniques. This review presents various guidelines and methods that are currently available for CRC screening, summarizes the rationale behind utilization of novel molecular-based diagnostic tests for CRC screening and prevention, and discusses appropriate screening techniques and intervals in populations of varying risk.

Entities:  

Mesh:

Year:  2017        PMID: 29099566

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  26 in total

1.  A fluorescent microsphere-based immunochromatographic strip is effective for quantitative fecal blood testing in colorectal cancer screening.

Authors:  Qingbing Wang; Jiwu Wang; Zeru Xiao; Zhiling Shen; Yanjun Wang; Yong Zhang; Tianyuan Pan; Jianan Xiao; Xiyuan Sun
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 3.940

2.  CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.

Authors:  Michelle Hong; Jian Hang Lam; Si-Lin Koo; Clarinda Wei Ling Chua; Kah Ling Lim; Felicia Wee; Wei Keat Wan; Wei Qiang Leow; Joo Guan Yeo; Iain Bee Huat Tan; Joe Yeong; Tony Kiat Hon Lim; Tong Seng Lim
Journal:  Cancer Immunol Immunother       Date:  2021-02-02       Impact factor: 6.630

3.  Upregulation of circular and linear METTL3 and USP3 in colorectal cancer.

Authors:  Bilal Alkhizzi; Mohammad Imran Khan; Ayat Al-Ghafari; Hani Choudhry
Journal:  Oncol Lett       Date:  2021-07-19       Impact factor: 3.111

Review 4.  Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.

Authors:  Chang Liu; Yunchen Yang; Yun Wu
Journal:  AAPS J       Date:  2018-03-08       Impact factor: 3.603

5.  Phenotype risk scores (PheRS) for pancreatic cancer using time-stamped electronic health record data: Discovery and validation in two large biobanks.

Authors:  Maxwell Salvatore; Lauren J Beesley; Lars G Fritsche; David Hanauer; Xu Shi; Alison M Mondul; Celeste Leigh Pearce; Bhramar Mukherjee
Journal:  J Biomed Inform       Date:  2020-12-03       Impact factor: 8.000

6.  Bacterial Alterations in Post-Cholecystectomy Patients Are Associated With Colorectal Cancer.

Authors:  Xinhua Ren; Jun Xu; Yuanyuan Zhang; Guodong Chen; Yiwen Zhang; Qing Huang; Yulan Liu
Journal:  Front Oncol       Date:  2020-08-12       Impact factor: 5.738

Review 7.  Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019.

Authors:  Niki Christou; Jeremy Meyer; Sotirios Popeskou; Valentin David; Christian Toso; Nicolas Buchs; Emilie Liot; Joan Robert; Frederic Ris; Muriel Mathonnet
Journal:  Biomed Res Int       Date:  2019-12-04       Impact factor: 3.246

8.  The IARC Perspective on Colorectal Cancer Screening.

Authors:  Béatrice Lauby-Secretan; Nadia Vilahur; Franca Bianchini; Neela Guha; Kurt Straif
Journal:  N Engl J Med       Date:  2018-03-26       Impact factor: 176.079

Review 9.  Microbial markers in colorectal cancer detection and/or prognosis.

Authors:  Romain Villéger; Amélie Lopès; Julie Veziant; Johan Gagnière; Nicolas Barnich; Elisabeth Billard; Delphine Boucher; Mathilde Bonnet
Journal:  World J Gastroenterol       Date:  2018-06-14       Impact factor: 5.374

10.  Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer.

Authors:  Dongmei Mai; Yanfen Zheng; Huan Guo; Peirong Ding; Ruihong Bai; Mei Li; Ying Ye; Jialiang Zhang; Xudong Huang; Dingxin Liu; Qiaoqi Sui; Ling Pan; Jiachun Su; Junge Deng; Guandi Wu; Rui Li; Shuang Deng; Yansen Bai; Yanan Ligu; Wen Tan; Chen Wu; Tangchun Wu; Jian Zheng; Dongxin Lin
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.